Transcriptome-Wide Investigation of Nuclear Rna-Binding

Total Page:16

File Type:pdf, Size:1020Kb

Transcriptome-Wide Investigation of Nuclear Rna-Binding TRANSCRIPTOME-WIDE INVESTIGATION OF NUCLEAR RNA-BINDING PROTEINS by ERIC NGUYEN B.A., B.S., University of Washington, 2009 A thesis submitted to the Faculty of the Graduate School of the University of Colorado in partial fulfillment of the requirements for the degree of Doctor of Philosophy Molecular Biology Program 2017 This thesis for the Doctor of Philosophy degree by Eric Nguyen has been approved for the Molecular Biology Program by Arthur Gutierrez-Hartmann, Chair Anthony Gerber Thomas Evans Patricia Ernst Matthew Taylor Aaron Johnson, Advisor Date: December 15th, 2017 ii Nguyen, Eric (PhD, Molecular Biology Program) Transcriptome-Wide Investigation of Nuclear RNA-Binding Proteins Thesis directed by Assistant Professor Aaron M. Johnson ABSTRACT RNA-binding proteins play a number of important roles throughout the cell. In order to more closely investigate their activity, we have adapted high-throughput techniques to characterize their activity across the transcriptome. We have previously identified heterogeneous nuclear ribonucleoprotein (hnRNP) A2/B1 as a potential adaptor protein for interactions between the chromatin silencing complex PRC2 and the RNA HOTAIR. We used enhanced cross- linking immunoprecipitation (eCLIP) to map the complete set of direct interactions between hnRNP A2/B1 and RNA in breast cancer cells. Surprisingly, a strong A2/B1 binding site occurs in the third intron of HOTAIR, which interrupts a known RNA- RNA interaction hotspot and is retained at a higher frequency than other HOTAIR introns. In vitro eCLIP experiments suggest that A2/B1 may redistribute to exonic binding sites once this intron is spliced. A2/B1 associates with multiple lncRNAs at regions that may contribute to regulation. Finally, we performed cellular fractionation to characterize the pattern of RNA association of A2/B1 in chromatin, nucleoplasm, and cytoplasm. We also examined the potential relevance of hnRNP A2/B1 in myogenesis. As A2/B1 has been associated with a number of muscle diseases, we performed eCLIP on A2/B1 in both undifferentiated mouse myoblasts and differentiated myotubes. We found that A2/B1 binds the 3′ UTR of transcripts in differentiated cells, and that these transcripts tended to be protein-coding. We also performed eCLIP on another iii protein TDP-43, that has been shown to directly interact with A2/B1 and be dysregulated in many of the same diseases. This experiment identified a number of exonic binding sites in myogenesis-associated transcripts, indicative of a role for TDP-43 in the nuclear export of long RNAs during myogenesis. Comparison of A2/B1 and TDP-43-bound transcripts shows some overlap, suggesting that they may act cooperatively in RNA regulation during myogenesis. Finally, we developed a novel method to investigate heterochromatin- associated RNA called hmRIP-seq, which was designed to differentiate between RNA-enzyme interactions leading to heterochromatin formation, and those that do not. This method identified a potential heterochromatin-interacting noncoding RNA, MTRNR2L12, that may direct silencing towards repetitive elements with similar sequence. The form and content of this abstract are approved. I recommend its publication. Approved: Aaron M. Johnson iv ACKNOWLEDGEMENTS This work would not have been possible without the assistance of many people. First and foremost, I would like to thanks my advisor, Aaron M. Johnson, for his invaluable advice and persistence in keeping the following projects on track as each one progressed. His copious comments on every paper, poster, and abstract were invariably helpful. I would also like to thank the graduate students with whom I have worked for the past four years, Alexis Zukowski and Maggie Balas, for their conversations and commiserations about life in the lab, and former lab members Emily Meredith and Karly Sindy for their invaluable mentorship and advice. Successful scientific endeavors rarely happen without outside help. For assistance with the eCLIP protocol I would like to thanks Gabriel Pratt and Eric van Nostrand, a chance conference encounter that became a lifeline for establishing their protocol in our lab. For assistance in imagining new frontiers for eCLIP I would like to thank Josh Wheeler and Tom Vogler for having the foresight to see how to include my work in their story. I would like to thank my thesis committee for their advice: Arthur Gutierrez- Hartmann, Tom Evans, Anthony Gerber, Patricia Ernst, and Matt Taylor. I would also like to acknowledge to contributions of former committee members Tobias Neff and David Bentley. I would like to thank the members of the Biochemistry and Molecular Genetics Department and Molecular Biology Program who have generously provided assistance: Nova Fong, Ryan Sheridan, Kerri York, and Monica Ransom for research v assistance; Sue Brozowski and Annie Vazquez for help navigating departmental bureaucracy; and Sabrena Heilman, Michele Hwozdyk-Parsons, and Bob Sclafani for running the Molecular Biology Program. I would like to thank the Medical Scientist Training Program for their continued support: Arthur Gutierrez-Hartmann and Angie Ribera for heading the program; Jodi Cropper, Emily Thomas, and Katie Bidus for administrative assistance; Sally Peach, Laura Hancock, Greg Kirkpatrick, Tamara Garcia, Ariel Hernandez, and Leon Zheng, the classmates with whom I entered this program six years ago; and Jingjing Zhang, Tom Vogler, Josh Wheeler, Dan Youmans, Matt Becker, Kelly Higa, Taylor Soderborg, Sarah Haeger, Jason Silver, and Mindy Szeto for their continued willingness to adventure around Denver. I would like to thank my previous mentors for helping to guide me to this career path: Bertil Hille, Willie Swanson, Pat Navas, and Jay Hesselberth. I would like to thank my parents, Ann and Toan Nguyen, for their continued advice and support, as well as my brother, Grant Nguyen. Last but not least, I would like to thank Charlotte Siska for being there for me at any time of day or night. vi TABLE OF CONTENTS CHAPTER I. INTRODUCTION ...................................................................................................... 1 Chromatin Biology .................................................................................................... 1 Epigenetic Modifications Have an Effect on Gene Regulation .......................... 1 Polycomb Proteins Form Gene Silencing Complexes ........................................ 3 PRC2 Activity is Modulated by Protein and RNA Cofactors .............................. 5 PRC2 Can Bind to Many RNAs .......................................................................... 6 PRC2 and Disease ............................................................................................... 8 Long Noncoding RNAs and Their Effects on Chromatin ........................................ 8 Long Noncoding RNAs: A New Class of RNA .................................................... 8 lncRNAs Can Bind to Specific Sites in the Genome ......................................... 10 Many lncRNAs Can Bind to PRC2 .................................................................... 12 PRC2-lncRNA Interactions are Implicated in Disease ..................................... 12 Many Proteins Bind lncRNAs and Affect Chromatin State .............................. 14 hnRNP A2/B1: A Multi-Faceted Protein ................................................................ 15 hnRNPs Comprise a Diverse Family of Nuclear Proteins ................................ 15 The Structure of hnRNP A2/B1 ......................................................................... 16 The Potential Roles of hnRNP A2/B1 ............................................................... 17 hnRNP B1 Binds HOTAIR and Its Targets with Specificity ............................. 19 hnRNP B1 May Act as an RNA Matchmaker on Chromatin ............................ 19 hnRNP A2/B1 in Disease ................................................................................. 20 Functional Interactions between RNA-Binding Proteins ...................................... 21 vii TDP-43 is a Splicing Regulator that Interacts with hnRNP A2/B1 .................. 21 Cytoplasmic TDP-43 and hnRNP A2/B1 can be Pathologic ............................ 22 Scope of Thesis ................................................................................................. 23 II. THE RNA INTERACTOME OF HNRNP A2/B1 ................................................... 36 Introduction ........................................................................................................... 36 Materials and Methods ........................................................................................... 37 Lessons Learned from HITS-CLIP and iCLIP Methods ................................... 37 The Enhanced CLIP (eCLIP) Method .............................................................. 38 Computational Analysis of eCLIP-seq Samples ................................................ 41 In vitro eCLIP ................................................................................................... 42 Cellular Fractionation of MCF7 Cells ............................................................... 43 RNA Isolation and PCR .................................................................................... 43 Results .................................................................................................................... 43 The hnRNP B1 Exon is Well-Conserved and Expressed in Mouse and Human .........................................................................................................................
Recommended publications
  • Genetic Variants in Humanin Nuclear Isoform Gene Regions Show No Association with Coronary Artery Disease
    Genetic variants in humanin nuclear isoform gene regions show no association with coronary artery disease Mall Eltermaa ( [email protected] ) University of Tartu https://orcid.org/0000-0002-9651-4107 Maili Jakobson University of Tartu Meeme Utt University of Tartu Sulev Kõks Perron Institute for Neurological and Translational Science Reedik Mägi University of Tartu Joel Starkopf Tartu University Hospital Research article Keywords: humanin, humanin-like, coronary artery disease, association study, peptide Posted Date: June 25th, 2019 DOI: https://doi.org/10.21203/rs.2.10582/v1 License: This work is licensed under a Creative Commons Attribution 4.0 International License. Read Full License Version of Record: A version of this preprint was published at BMC Research Notes on November 21st, 2019. See the published version at https://doi.org/10.1186/s13104-019-4807-x. Loading [MathJax]/jax/output/CommonHTML/jax.js Page 1/7 Abstract Background Coronary artery disease contributes to noncommunicable disease deaths worldwide. In order to make preventive methods more accurate, we need to know more about the development and progress of this pathology, including the genetic aspects. Humanin is a small peptide known for its cytoprotective and anti-apoptotic properties. Our study looked for genomic associations between humanin-like nuclear isoform genes and coronary artery disease using CARDIoGRAMplusC4D Consortium data. Results Lookup from meta-analysis datasets gave single nucleotide polymorphisms in all 13 humanin-like nuclear isoform genes with the lowest P-value for rs6151662 from the MTRNR2L2 gene including the 50 kb anking region in both directions (P-value = 0.0037). Within the gene region alone the top variant was rs78083998 from the MTRNR2L13 region (meta-analysis P-value=0.042).
    [Show full text]
  • A Clinicopathological and Molecular Genetic Analysis of Low-Grade Glioma in Adults
    A CLINICOPATHOLOGICAL AND MOLECULAR GENETIC ANALYSIS OF LOW-GRADE GLIOMA IN ADULTS Presented by ANUSHREE SINGH MSc A thesis submitted in partial fulfilment of the requirements of the University of Wolverhampton for the degree of Doctor of Philosophy Brain Tumour Research Centre Research Institute in Healthcare Sciences Faculty of Science and Engineering University of Wolverhampton November 2014 i DECLARATION This work or any part thereof has not previously been presented in any form to the University or to any other body whether for the purposes of assessment, publication or for any other purpose (unless otherwise indicated). Save for any express acknowledgments, references and/or bibliographies cited in the work, I confirm that the intellectual content of the work is the result of my own efforts and of no other person. The right of Anushree Singh to be identified as author of this work is asserted in accordance with ss.77 and 78 of the Copyright, Designs and Patents Act 1988. At this date copyright is owned by the author. Signature: Anushree Date: 30th November 2014 ii ABSTRACT The aim of the study was to identify molecular markers that can determine progression of low grade glioma. This was done using various approaches such as IDH1 and IDH2 mutation analysis, MGMT methylation analysis, copy number analysis using array comparative genomic hybridisation and identification of differentially expressed miRNAs using miRNA microarray analysis. IDH1 mutation was present at a frequency of 71% in low grade glioma and was identified as an independent marker for improved OS in a multivariate analysis, which confirms the previous findings in low grade glioma studies.
    [Show full text]
  • CSE642 Final Version
    Eindhoven University of Technology MASTER Dimensionality reduction of gene expression data Arts, S. Award date: 2018 Link to publication Disclaimer This document contains a student thesis (bachelor's or master's), as authored by a student at Eindhoven University of Technology. Student theses are made available in the TU/e repository upon obtaining the required degree. The grade received is not published on the document as presented in the repository. The required complexity or quality of research of student theses may vary by program, and the required minimum study period may vary in duration. General rights Copyright and moral rights for the publications made accessible in the public portal are retained by the authors and/or other copyright owners and it is a condition of accessing publications that users recognise and abide by the legal requirements associated with these rights. • Users may download and print one copy of any publication from the public portal for the purpose of private study or research. • You may not further distribute the material or use it for any profit-making activity or commercial gain Eindhoven University of Technology MASTER THESIS Dimensionality Reduction of Gene Expression Data Author: S. (Sako) Arts Daily Supervisor: dr. V. (Vlado) Menkovski Graduation Committee: dr. V. (Vlado) Menkovski dr. D.C. (Decebal) Mocanu dr. N. (Nikolay) Yakovets May 16, 2018 v1.0 Abstract The focus of this thesis is dimensionality reduction of gene expression data. I propose and test a framework that deploys linear prediction algorithms resulting in a reduced set of selected genes relevant to a specified case. Abstract In cancer research there is a large need to automate parts of the process of diagnosis, this is mainly to reduce cost, make it faster and more accurate.
    [Show full text]
  • Characterisation of the Genomic Landscape of CRLF2‐Rearranged Acute Lymphoblastic Leukemia
    Characterisation of the Genomic Landscape of CRLF2- rearranged Acute Lymphoblastic Leukemia Lisa J Russell1*, Lisa Jones1, Amir Enshaei1, Stefano Tonin1, Sarra L Ryan1, Jeyanthy Eswaran1 , Sirintra Nakjang2, Elli Papaemmanuil3,4, Jose M C Tubio4, Adele K Fielding5, Ajay Vora6, Peter J Campbell4, Anthony V Moorman1, and Christine J Harrison1 1 Leukaemia Research Cytogenetics Group, Northern Institute for Cancer Research, Newcastle University, Newcastle-upon-Tyne, UK 2 Bioinformatics Support Unit, Newcastle University, Newcastle-upon-Tyne, UK 3 Memorial Sloan Kettering Cancer Center, USA 4 Cancer Genome Project, Wellcome Trust Sanger Institute, Hinxton, UK 5 Research Department of Haemaoloty, UCL Cancer Institute, London, UK 6 Department of Haematology, Sheffield Children’s Hospital, Sheffield, UK; AVM and CJH contributed equally to this study Running Title – Genomic landscape of CRLF2 rearranged leukemia Correspondence to: Dr Lisa J Russell, Wolfson Childhood Cancer Research Centre, Northern Institute for Cancer Research, Newcastle University, Level 6, Herschel Building, Brewery Lane, Newcastle upon Tyne, NE1 7RU, [email protected]. Acknowledgements Support by: The Kay Kendall Leukaemia Fund, Leuka, European Haematology Association and Bloodwise (formerly Leukaemia and Lymphoma Research) This article has been accepted for publication and undergone full peer review but has not been through the copyediting, typesetting, pagination and proofreading process which may lead to differences between this version and the Version of Record. Please cite this article as an ‘Accepted Article’, doi: 10.1002/gcc.22439 This article is protected by copyright. All rights reserved. Genes, Chromosomes & Cancer Page 2 of 147 Deregulated expression of the type I cytokine receptor, CRLF2, is observed in 5-15% of precursor B-cell acute lymphoblastic leukaemia (B-ALL).
    [Show full text]
  • Genetic Variants in Humanin Nuclear Isoform
    Eltermaa et al. BMC Res Notes (2019) 12:759 https://doi.org/10.1186/s13104-019-4807-x BMC Research Notes RESEARCH NOTE Open Access Genetic variants in humanin nuclear isoform gene regions show no association with coronary artery disease Mall Eltermaa1* , Maili Jakobson1, Meeme Utt1,2, Sulev Kõks3,4, Reedik Mägi5 and Joel Starkopf6 Abstract Objective: Coronary artery disease contributes to noncommunicable disease deaths worldwide. In order to make preventive methods more accurate, we need to know more about the development and progress of this pathology, including the genetic aspects. Humanin is a small peptide known for its cytoprotective and anti-apoptotic properties. Our study looked for genomic associations between humanin-like nuclear isoform genes and coronary artery disease using CARDIoGRAMplusC4D Consortium data. Results: Lookup from meta-analysis datasets gave single nucleotide polymorphisms in all 13 humanin-like nuclear isoform genes with the lowest P value for rs6151662 from the MTRNR2L2 gene including the 50 kb fanking region in both directions (P-value 0.0037). Within the gene region alone the top variant was rs78083998 from the MTRNR2L13 region (meta-analysis P-value= 0.042). None of the found associations were statistically signifcant after correction for multiple testing. Lookup for expression= trait loci in these gene regions gave no statistically signifcant variants. Keywords: Humanin, Humanin-like, Coronary artery disease, Association study, Peptide Introduction identifed, expanding the total to 161 [3]. Tere are genes Cardiovascular diseases account for most noncommu- known to have a large efect on, for example, lipoprotein nicable disease (NCD) deaths worldwide [1]. Te WHO metabolism (e.g.
    [Show full text]
  • Characterization of Nucleic Acids from Extracellular Vesicle-Enriched
    Bart et al. BMC Genomics (2021) 22:425 https://doi.org/10.1186/s12864-021-07733-9 RESEARCH Open Access Characterization of nucleic acids from extracellular vesicle-enriched human sweat Geneviève Bart1, Daniel Fischer2, Anatoliy Samoylenko1, Artem Zhyvolozhnyi1, Pavlo Stehantsev1, Ilkka Miinalainen1, Mika Kaakinen1, Tuomas Nurmi1, Prateek Singh1,3, Susanna Kosamo1, Lauri Rannaste4, Sirja Viitala2, Jussi Hiltunen4 and Seppo J Vainio1* Abstract Background: The human sweat is a mixture of secretions from three types of glands: eccrine, apocrine, and sebaceous. Eccrine glands open directly on the skin surface and produce high amounts of water-based fluid in response to heat, emotion, and physical activity, whereas the other glands produce oily fluids and waxy sebum. While most body fluids have been shown to contain nucleic acids, both as ribonucleoprotein complexes and associated with extracellular vesicles (EVs), these have not been investigated in sweat. In this study we aimed to explore and characterize the nucleic acids associated with sweat particles. Results: We used next generation sequencing (NGS) to characterize DNA and RNA in pooled and individual samples of EV-enriched sweat collected from volunteers performing rigorous exercise. In all sequenced samples, we identified DNA originating from all human chromosomes, but only the mitochondrial chromosome was highly represented with 100% coverage. Most of the DNA mapped to unannotated regions of the human genome with some regions highly represented in all samples. Approximately 5 % of the reads were found to map to other genomes: including bacteria (83%), archaea (3%), and virus (13%), identified bacteria species were consistent with those commonly colonizing the human upper body and arm skin.
    [Show full text]
  • Biological Role and Disease Impact of Copy Number Variation in Complex Disease
    University of Pennsylvania ScholarlyCommons Publicly Accessible Penn Dissertations 2014 Biological Role and Disease Impact of Copy Number Variation in Complex Disease Joseph Glessner University of Pennsylvania, [email protected] Follow this and additional works at: https://repository.upenn.edu/edissertations Part of the Bioinformatics Commons, and the Genetics Commons Recommended Citation Glessner, Joseph, "Biological Role and Disease Impact of Copy Number Variation in Complex Disease" (2014). Publicly Accessible Penn Dissertations. 1286. https://repository.upenn.edu/edissertations/1286 This paper is posted at ScholarlyCommons. https://repository.upenn.edu/edissertations/1286 For more information, please contact [email protected]. Biological Role and Disease Impact of Copy Number Variation in Complex Disease Abstract In the human genome, DNA variants give rise to a variety of complex phenotypes. Ranging from single base mutations to copy number variations (CNVs), many of these variants are neutral in selection and disease etiology, making difficult the detection of true common orar r e frequency disease-causing mutations. However, allele frequency comparisons in cases, controls, and families may reveal disease associations. Single nucleotide polymorphism (SNP) arrays and exome sequencing are popular assays for genome-wide variant identification. oT limit bias between samples, uniform testing is crucial, including standardized platform versions and sample processing. Bases occupy single points while copy variants occupy segments.
    [Show full text]
  • BRASTIANOS, Kaliopi Priscilla [US/US]; C/O 55 Fruit Street, Boston, Massachusets 021 14 (US)
    ( (51) International Patent Classification: (72) Inventors; and C12Q 1/6886 (2018.01) (71) Applicants: BRASTIANOS, Kaliopi Priscilla [US/US]; c/o 55 Fruit Street, Boston, Massachusets 021 14 (US). (21) International Application Number: ALVAREZ-BRECKENRIDGE, Christopher Allen PCT/US20 19/035252 [US/US]; c/o 55 Fruit Street, Boston, Massachusetts 021 14 (22) International Filing Date: (US). 03 June 2019 (03.06.2019) (72) Inventors: SHALEK, Alexander K.; c/o 77 Massa¬ (25) Filing Language: English chusets Avenue, Cambridge, Massachusetts 02139 (US). CARTER, Scott; c/o 450 Brookline Avenue, Boston, (26) Publication Language: English Massachusetts 02215 (US). PRAKADAN, Sanjay; c/o 77 (30) Priority Data: Massachusetts Avenue, Cambridge, Massachusetts 02139 62/679,728 0 1 June 2018 (01.06.2018) US (US). (71) Applicants: MASSACHUSETTS INSTITUTE OF (74) Agent: SCHER, Michael B. et al.; Johnson, Marcou & TECHNOLOGY [US/US]; 77 Massachusets Avenue, Isaacs, LLC, P.O. Box 691, Hoschton, Georgia 30548 (US). Cambridge, Massachusets 02139 (US). THE GENER¬ (81) Designated States (unless otherwise indicated, for every AL HOSPITAL CORPORATION [US/US]; 55 Fruit kind of national protection av ailable) . AE, AG, AL, AM, Street, Boston, Massachusetts 021 14 (US). DANA-FAR- AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, BER CANCER INSTITUTE, INC. [US/US]; 450 Brook¬ CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, DO, line Avenue, Boston, Massachusetts 02215 (US). DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, (54) Title: METHODS AND COMPOSITIONS FOR DETECTING AND MODULATING MICROENVIRONMENT GENE SIG¬ NATURES FROM THE CSF OF METASTASIS PATIENTS FIG.
    [Show full text]
  • Bioprinted Mcf7 Breast Cancer Cells, an in Vitro Model for Drug Discovery
    University of Texas at El Paso ScholarWorks@UTEP Open Access Theses & Dissertations 2019-01-01 Bioprinted Mcf7 Breast Cancer Cells, An In Vitro Model For Drug Discovery Aleli Campbell University of Texas at El Paso Follow this and additional works at: https://digitalcommons.utep.edu/open_etd Part of the Biomedical Commons Recommended Citation Campbell, Aleli, "Bioprinted Mcf7 Breast Cancer Cells, An In Vitro Model For Drug Discovery" (2019). Open Access Theses & Dissertations. 2834. https://digitalcommons.utep.edu/open_etd/2834 This is brought to you for free and open access by ScholarWorks@UTEP. It has been accepted for inclusion in Open Access Theses & Dissertations by an authorized administrator of ScholarWorks@UTEP. For more information, please contact [email protected]. BIOPRINTED MCF7 BREAST CANCER CELLS, AN IN VITRO MODEL FOR DRUG DISCOVERY ALELI CAMPBELL Doctoral Program in Biomedical Engineering APPROVED Thomas Boland, Ph.D, Chair Armando Varela-Ramirez, Ph.D Wei Qian, Ph.D Alexander Philipovskiy, M.D.,Ph.D Stephen Crites, Ph.D Dean of Graduate School Copyright © by Aleli Campbell 2019 Dedication To my beloved ever patient husband, Ron, and my children, Kevin and Deanna. BIOPRINTED MCF7 BREAST CANCER CELLS, AN IN VITRO MODEL FOR DRUG DISCOVERY by ALELI CAMPBELL, M.S. DISSERTATION Presented to the Faculty of the Graduate School of The University of Texas at El Paso in Partial Fulfillment of the Requirements for the Degree of DOCTOR OF PHILOSOPHY Metallurgical, Materials and Biomedical Engineering THE UNIVERSITY OF TEXAS AT EL PASO December 2019 Acknowledgements I would like to thank my PhD advisor, Dr. Thomas Boland, for his guidance and support during the PhD program.
    [Show full text]
  • SUPPLEMENTARY DATA Supplementary Table 1. Characteristics of the Organ Donors and Human Islet Preparations Used for RNA-Seq
    SUPPLEMENTARY DATA Supplementary Table 1. Characteristics of the organ donors and human islet preparations used for RNA-seq and independent confirmation and mechanistic studies. Gender Age BMI Cause of death Purity (years) (kg/m2) (%) F 77 23.8 Trauma 45 M 36 26.3 CVD 51 M 77 25.2 CVD 62 F 46 22.5 CVD 60 M 40 26.2 Trauma 34 M 59 26.7 NA 58 M 51 26.2 Trauma 54 F 79 29.7 CH 21 M 68 27.5 CH 42 F 76 25.4 CH 30 F 75 29.4 CVD 24 F 73 30.0 CVD 16 M 63 NA NA 46 F 64 23.4 CH 76 M 69 25.1 CH 68 F 23 19.7 Trauma 70 M 47 27.7 CVD 48 F 65 24.6 CH 58 F 87 21.5 Trauma 61 F 72 23.9 CH 62 M 69 25 CVD 85 M 85 25.5 CH 39 M 59 27.7 Trauma 56 F 76 19.5 CH 35 F 50 20.2 CH 70 F 42 23 CVD 48 M 52 24.5 CH 60 F 79 27.5 CH 89 M 56 24.7 Cerebral ischemia 47 M 69 24.2 CVD 57 F 79 28.1 Trauma 61 M 79 23.7 NA 13 M 82 23 CH 61 M 32 NA NA 75 F 23 22.5 Cardiac arrest 46 M 51 NA Trauma 37 Abbreviations: F: Female; M: Male; BMI: Body mass index; CVD: Cardiovascular disease; CH: Cerebral hemorrhage.
    [Show full text]
  • A Molecular Cytogenetic Investigation of Secondary Abnormalities and Clonal Evolution in ETV6-RUNX1 Positive Acute Lymphoblastic Leukaemia
    A molecular cytogenetic investigation of secondary abnormalities and clonal evolution in ETV6-RUNX1 positive acute lymphoblastic leukaemia Halima Hamdan Abdullah Al-Shehhi Thesis submitted for the degree of Doctor of Philosophy Newcastle University Faculty of Medical Sciences Northern Institute for Cancer Research July 2014 Declaration I certify that no part of the material documented in this thesis has previously been submitted for a degree or other qualification in this or any other university. I declare that this thesis represents my own unaided work, carried out by myself, except where it is acknowledged otherwise in the thesis text. Halima Al-Shehhi July 2014 i Acknowledgements I would like to express my sincere gratitude to my supervisors, Professor Anthony Moorman and Professor Christine Harrison for their unstinting support, encouragement, motivation, enthusiasm, and immense knowledge throughout my PhD study and research. Next, I would like to thank the past and present members of the Leukaemia Research Cytogenetic Group: Dr Amy Erhorn, Dr Alem Gabriel, Claire Schwab, Dr Lucy Chilton, Heather Morrison, Dr Lisa Russell, Dr Sarra Ryan, Dino Mašić, Jake Clayton, Alannah Elliott, Stacey Richardson, Dr Amir Enshaie and Dr Paul Sinclair for all support and help in terms of learning new techniques, comprehensive MLPA screening, review scoring of FISH slides, providing cell lines, SNP array analysis, statistical analysis and sharing knowledge/ ideas. Within the wider NICR, I would like to thank Dr Julie Irving, Elizabeth Matheson, Marian Case and the summer placement student: Alysia Davies for their expertise in helping the establishment of copy number q PCR in the lab and providing a positive control cell line.
    [Show full text]
  • Genomic Analysis of Human Spinal Deformity and Characterization of a Zebrafish Disease Model Jillian Gwen Buchan Washington University in St
    Washington University in St. Louis Washington University Open Scholarship All Theses and Dissertations (ETDs) Spring 4-22-2014 Genomic Analysis of Human Spinal Deformity and Characterization of a Zebrafish Disease Model Jillian Gwen Buchan Washington University in St. Louis Follow this and additional works at: https://openscholarship.wustl.edu/etd Recommended Citation Buchan, Jillian Gwen, "Genomic Analysis of Human Spinal Deformity and Characterization of a Zebrafish Disease Model" (2014). All Theses and Dissertations (ETDs). 1223. https://openscholarship.wustl.edu/etd/1223 This Dissertation is brought to you for free and open access by Washington University Open Scholarship. It has been accepted for inclusion in All Theses and Dissertations (ETDs) by an authorized administrator of Washington University Open Scholarship. For more information, please contact [email protected]. WASHINGTON UNIVERSITY IN ST. LOUIS Division of Biology & Biomedical Sciences Molecular Genetics and Genomics Dissertation Examination Committee: Christina A. Gurnett, Chair Carlos Cruchaga Alison M. Goate Matthew I. Goldsmith Kelly R. Monk Lilianna Solnica-Krezel Genomic Analysis of Human Spinal Deformity and Characterization of a Zebrafish Disease Model by Jillian Gwen Buchan A dissertation presented to the Graduate School of Arts and Sciences of Washington University in partial fulfillment of the requirements for the degree of Doctor of Philosophy May 2014 St. Louis, Missouri TABLE OF CONTENTS List of Figures ….………………………………………………………………………… iv List of Tables
    [Show full text]